These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2457219)

  • 21. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Natural substances with a diketopiperazine structure].
    Johne S; Gröger D
    Pharmazie; 1977 Jan; 32(1):1-16. PubMed ID: 840871
    [No Abstract]   [Full Text] [Related]  

  • 24. The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines.
    Waring P; Eichner RD; Müllbacher A
    Med Res Rev; 1988; 8(4):499-524. PubMed ID: 2461498
    [No Abstract]   [Full Text] [Related]  

  • 25. Diketopiperazines as a new class of platelet-activating factor inhibitors.
    Shimazaki N; Shima I; Hemmi K; Hashimoto M
    J Med Chem; 1987 Oct; 30(10):1706-9. PubMed ID: 3656347
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet activating factor antagonists.
    Summers JB; Albert DH
    Adv Pharmacol; 1995; 32():67-168. PubMed ID: 7748804
    [No Abstract]   [Full Text] [Related]  

  • 27. Design and modeling of new platelet-activating factor antagonists. 3. Relative importance of hydrophobicity and electronic distribution in piperazinic series.
    Heymans F; Dive G; Lamouri A; Bellahsene T; Touboul E; Huet J; Tavet F; Redeuilh C; Godfroid JJ
    J Lipid Mediat Cell Signal; 1997 Jan; 15(2):161-73. PubMed ID: 9034962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Diversity and Biological Activities of the Cyclodipeptides from Fungi.
    Wang X; Li Y; Zhang X; Lai D; Zhou L
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29168781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells.
    Hayashi H; Kudo I; Kato T; Nozawa R; Nojima S; Inoue K
    Lipids; 1988 Dec; 23(12):1119-24. PubMed ID: 2852289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological response of guinea pig peritoneal macrophages to platelet-activating factor.
    Hayashi H; Kudo I; Nojima S; Inoue K
    Lipids; 1991 Dec; 26(12):1193-9. PubMed ID: 1668117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.
    Kudo I; Kato T; Hayashi H; Yanoshita R; Ikizawa K; Uda H; Inoue K
    Lipids; 1991 Dec; 26(12):1065-70. PubMed ID: 1668106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity.
    Sallem W; Serradji N; Dereuddre-Bosquet N; Dive G; Clayette P; Heymans F
    Bioorg Med Chem; 2006 Dec; 14(23):7999-8013. PubMed ID: 16908170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAF inhibitors of microbial origin. Studies on diketopiperazine derivatives.
    Yoshida K; Okamoto M; Shimazaki N; Hemmi K
    Prog Biochem Pharmacol; 1988; 22():66-80. PubMed ID: 2457219
    [No Abstract]   [Full Text] [Related]  

  • 34. Diketopiperazine derivatives, a new series of platelet-activating factor inhibitors.
    Shimazaki N; Shima I; Hemmi K; Tsurumi Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3527-30. PubMed ID: 3427732
    [No Abstract]   [Full Text] [Related]  

  • 35. PAF inhibitory activity of diketopiperazines: structure-activity relationships.
    Shimazaki N; Shima I; Okamoto M; Yoshida K; Hemmi K; Hashimoto M
    Lipids; 1991 Dec; 26(12):1175-8. PubMed ID: 1819704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.